Article
M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer
30 Dec 2020
Abstract excerpt
The efficacy of PD-1/PD-L1 blockades is heterogeneous in different molecular subtypes of gastric cancer (GC). In this study, we analyzed relevant clinical trials to identify the molecular subtypes associated with the efficacy of PD-1/PD-L1 blockades, and public datasets, patient samples, and GC cell lines were used for investigating potential mechanisms. We found that GC with EBV-positive, MSI-H/dMMR, TMB-H or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.